Biocon Ltd News Today

The first approval is for the 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths of Lenalidomide Capsules.

Civica will start selling the medicine for patients in the United States after completing development work and clinical trials.

The drug is also used to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) in adults who have shown resistance or intolerance to prior therapy.

Biocon will market Liraglutide under two brand names - Liraglutide Biocon for diabetes, which is a generic version of Victoza.

As per the company, YESINTEK shall be available in all the same formulations currently provided by Stelara.

Here are some of the stocks that may see significant price movement today: Biocon, NTPC Green Energy, LIC, etc.

Biocon's EBITDA increased by 16% YoY to ₹787 crore, which shows improved operational performance.

Here are some of the stocks that may see significant price movement today: Avenue Supermarts, Just Dial, PCBL, etc.

The approval further adds to Biocon's portfolio of complex drug products and will be commercialised in the region expeditiously

Here are some of the stocks that may see significant price movement today: Varun Beverages, NHPC, Hindustan Zinc, etc.